Concepedia

David Guyon

DG

4

Publications

72

Citations

4

H-Index

2020

Active since

Affiliations

Inserm(Current)

Institut du Cerveau

Sorbonne Université

Centre National de la Recherche Scientifique

Institut Curie

David Guyon is an author at Inserm specializing in high-grade gliomas, oncology, and glioma.

Top concepts

Publications per year

2020–2024

4

Publications

4

Sustained Tumor Control With MAPK Inhibition in <i>BRAF</i> V600–Mutant Adult Glial and Glioneuronal Tumors

Giulia Berzero, Luisa Bellu, Capucine Baldini et al. · Neurology · 2021 · 28 citations

Medical debulking with BRAF/MEK inhibitors in aggressive <i>BRAF</i>-mutant craniopharyngioma

Anna Luisa Di Stefano, David Guyon, Karine Sejean et al. · Neuro-Oncology Advances · 2020 · 21 citations · Full text

Bevacizumab in real-life patients with recurrent glioblastoma: benefit or futility?

Cristina Smolenschi, Elie Rassy, Johan Pallud et al. · Journal of Neurology · 2023 · 13 citations

, , +8

Real life data of ONC201 (dordaviprone) in pediatric and adult H3K27-altered recurrent diffuse midline glioma: Results of an international academia-driven compassionate use program

Daniela Di Carlo, Maxime Annereau, Marina Vignes et al. · European Journal of Cancer · 2024 · 10 citations · Full text

Rows per page

1–4 of 4